Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons. Issue 5 (8th January 2020)
- Record Type:
- Journal Article
- Title:
- Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons. Issue 5 (8th January 2020)
- Main Title:
- Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons
- Authors:
- Majidinia, Maryam
Mirza‐Aghazadeh‐Attari, Mohammad
Rahimi, Mahdi
Mihanfar, Ainaz
Karimian, Ansar
Safa, Amin
Yousefi, Bahman - Abstract:
- Abstract: Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both conventional and novel chemotherapy agents, is an important barrier in treating malignancies. Initially, it was discovered that cellular pumps dependent on ATP were the cause of resistance to chemotherapy, and further studies have found that other mechanisms such as increased metabolism of drugs, decreased drug entry, and defective apoptotic pathways are involved in this process. MDR has been the focus of numerous initiatives and countless studies have been undertaken to better understand MDR and formulate strategies to overcome its effects. The current review highlights various nano‐drug delivery systems including polymeric/solid lipid/mesoporous silica/metal nanoparticles, dendrimers, liposomes, micelles, and nanostructured lipid carriers to overcome the mechanism of MDR. Nanoparticles are novel gateways to enhance the therapeutic efficacy of anticancer agents at the target site of action due to their tumor‐targeting abilities, which can limit the unwanted systemic effects of chemotherapy agents and also reduce drug resistance. Additionally, other innovative strategies including RNA interference as a biological process used to inhibit or silence specific gene expression, natural products as MDR modulators with little systemic toxic effects, which interfere with the functions of proteins involved in drug efflux, and physical approaches such as combination of conventionalAbstract: Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both conventional and novel chemotherapy agents, is an important barrier in treating malignancies. Initially, it was discovered that cellular pumps dependent on ATP were the cause of resistance to chemotherapy, and further studies have found that other mechanisms such as increased metabolism of drugs, decreased drug entry, and defective apoptotic pathways are involved in this process. MDR has been the focus of numerous initiatives and countless studies have been undertaken to better understand MDR and formulate strategies to overcome its effects. The current review highlights various nano‐drug delivery systems including polymeric/solid lipid/mesoporous silica/metal nanoparticles, dendrimers, liposomes, micelles, and nanostructured lipid carriers to overcome the mechanism of MDR. Nanoparticles are novel gateways to enhance the therapeutic efficacy of anticancer agents at the target site of action due to their tumor‐targeting abilities, which can limit the unwanted systemic effects of chemotherapy agents and also reduce drug resistance. Additionally, other innovative strategies including RNA interference as a biological process used to inhibit or silence specific gene expression, natural products as MDR modulators with little systemic toxic effects, which interfere with the functions of proteins involved in drug efflux, and physical approaches such as combination of conventional drug administration with thermal/ultrasound/photodynamic strategies are also highlighted. … (more)
- Is Part Of:
- IUBMB life. Volume 72:Issue 5(2020)
- Journal:
- IUBMB life
- Issue:
- Volume 72:Issue 5(2020)
- Issue Display:
- Volume 72, Issue 5 (2020)
- Year:
- 2020
- Volume:
- 72
- Issue:
- 5
- Issue Sort Value:
- 2020-0072-0005-0000
- Page Start:
- 855
- Page End:
- 871
- Publication Date:
- 2020-01-08
- Subjects:
- multidrug resistance -- nanoparticles -- natural products -- physical approaches -- RNA interference
Biochemistry -- Periodicals
Molecular biology -- Periodicals
572.8 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-6551 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/iub.2215 ↗
- Languages:
- English
- ISSNs:
- 1521-6543
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4588.826000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13162.xml